(Q38188908)

30 August 2017

0 references

Effect of L-carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis (English)

1 reference

30 August 2017

1 reference

1 reference

1 reference

Shi-Kun Yang

1

1 reference

30 August 2017

Li Xiao

2

1 reference

30 August 2017

Pan-Ai Song

3

1 reference

30 August 2017

Xiaoxuan Xu

4

1 reference

30 August 2017

Fu-You Liu

5

1 reference

30 August 2017

Lin Sun

6

1 reference

30 August 2017

language of work or name

1 reference

17 December 2013

1 reference

30 August 2017

published in

Journal of Nephrology

1 reference

30 August 2017

volume

27

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

317-329

1 reference

Artificial kidney function; kinetics of hemodialysis

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

A review of the impact of l-carnitine therapy on patient functionality in maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

The importance of illness perception in end-stage renal disease: associations with psychosocial and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Carnitine in metabolic disease: potential for pharmacological intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

L carnitine in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effects of L-carnitine on oxidative stress responses in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Dialysis-related carnitine disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Pharmacological effects and clinical applications of propionyl-L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Protective effect of L-carnitine against H(2)O(2)-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effect of L-carnitine on erythroid colony formation in mouse bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes St

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

L-carnitine supplementation in humans. The effects on physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-013-0002-7

Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial

21 January 2018

1 reference

12 December 2020

Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation

1 reference

12 December 2020

Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial

1 reference

12 December 2020

Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients

1 reference

12 December 2020

Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy

1 reference

12 December 2020

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects

1 reference

12 December 2020

Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency

1 reference

12 December 2020

Body composition and long-term levo-carnitine supplementation.

1 reference

12 December 2020

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects

1 reference

12 December 2020

A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis

1 reference

12 December 2020

Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis.

1 reference

12 December 2020

High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis

1 reference

12 December 2020

The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure

1 reference

12 December 2020

L-carnitine supplementation in hemodialysis patients.

1 reference

12 December 2020

The role of oral L-carnitine therapy in chronic hemodialysis patients

1 reference

12 December 2020

Nutritional effects of carnitine supplementation in hemodialysis patients.

1 reference

12 December 2020

Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.

1 reference

12 December 2020

[Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients]

1 reference

12 December 2020

The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients

1 reference

12 December 2020

10.1007/S40620-013-0002-7

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1037696829

0 references

1 reference